Lantheus Holdings, Inc. Unrecognized Tax Benefits, Period Increase (Decrease)
Lantheus Holdings, Inc. (LNTH) reported Unrecognized Tax Benefits, Period Increase (Decrease) of -$17.10 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2020-02-25
- Lantheus Holdings, Inc. unrecognized tax benefits, period increase (decrease) for the quarter ending 2019-09-30 was -$1.50M.
- Lantheus Holdings, Inc. unrecognized tax benefits, period increase (decrease) for fiscal 2019 was -$17.10M.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 3 month | Unrecognized Tax Benefits, Period Increase (Decrease) 12 month |
|---|---|---|
| 2019-12-31 | -$17.10M 10-K · filed 2020-02-25 | |
| 2019-09-30 | -$1.50M 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |